Han JY - Search Results

1

Proteogenomic characterization identifies clinical subgroups in EGFR and ALK wild-type never-smoker lung adenocarcinoma.

Kim H, Lee W, Kim Y, Lee SJ, Choi W, Lee GK, Park SJ, Ju S, Kim SY, Lee C, Han JY. Kim H, et al. Among authors: han jy. Exp Mol Med. 2024 Sep;56(9):2082-2095. doi: 10.1038/s12276-024-01320-0. Epub 2024 Sep 19. Exp Mol Med. 2024. PMID: 39300154 Free PMC article.

2

Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.

Han JY, Lee GK, Jang DH, Lee SY, Lee JS. Han JY, et al. Cancer. 2008 Aug 15;113(4):799-807. doi: 10.1002/cncr.23668. Cancer. 2008. PMID: 18618574 Free article.

3

Association of SUMO1 and UBC9 genotypes with tumor response in non-small-cell lung cancer treated with irinotecan-based chemotherapy.

Han JY, Lee GK, Yoo SY, Yoon SJ, Cho EY, Kim HT, Lee JS. Han JY, et al. Pharmacogenomics J. 2010 Apr;10(2):86-93. doi: 10.1038/tpj.2009.46. Epub 2009 Oct 27. Pharmacogenomics J. 2010. PMID: 19859084

4

First-line gefitinib treatment for patients with advanced non-small cell lung cancer with poor performance status.

Lee YJ, Kim HT, Han JY, Yun T, Lee GK, Kim HY, Sung JH, Lee JS. Lee YJ, et al. Among authors: han jy. J Thorac Oncol. 2010 Mar;5(3):361-8. doi: 10.1097/JTO.0b013e3181cee1ea. J Thorac Oncol. 2010. PMID: 20107420 Free article.

5

A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population.

Yoon KA, Park JH, Han J, Park S, Lee GK, Han JY, Zo JI, Kim J, Lee JE, Takahashi A, Kubo M, Nakamura Y, Lee JS. Yoon KA, et al. Among authors: han j, han jy. Hum Mol Genet. 2010 Dec 15;19(24):4948-54. doi: 10.1093/hmg/ddq421. Epub 2010 Sep 28. Hum Mol Genet. 2010. PMID: 20876614

6

DNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinoma.

Han JY, Yoon KA, Park JH, Lee YJ, Lee GK, Han JH, Yoon SJ, Yun T, Kim HT, Lee JS. Han JY, et al. Among authors: han jh. Cancer. 2011 Jul 15;117(14):3201-8. doi: 10.1002/cncr.25863. Epub 2011 Jan 24. Cancer. 2011. PMID: 21264830 Free article.

7

Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy.

Lee YJ, Yoon KA, Han JY, Kim HT, Yun T, Lee GK, Kim HY, Lee JS. Lee YJ, et al. Among authors: han jy. Clin Cancer Res. 2011 Aug 1;17(15):5179-87. doi: 10.1158/1078-0432.CCR-11-0400. Epub 2011 Jun 8. Clin Cancer Res. 2011. PMID: 21653691 Clinical Trial.

8

Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations.

Won YW, Han JY, Lee GK, Park SY, Lim KY, Yoon KA, Yun T, Kim HT, Lee JS. Won YW, et al. Among authors: han jy. J Clin Pathol. 2011 Nov;64(11):947-52. doi: 10.1136/jclinpath-2011-200169. Epub 2011 Jul 1. J Clin Pathol. 2011. PMID: 21725039

9

Impact of EGFR tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung.

Lee Y, Han JY, Kim HT, Yun T, Lee GK, Kim HY, Lee JS. Lee Y, et al. Among authors: han jy. J Neurooncol. 2013 Oct;115(1):95-101. doi: 10.1007/s11060-013-1199-y. Epub 2013 Jul 6. J Neurooncol. 2013. PMID: 23832498 Clinical Trial.

10

Post-progression survival in patients with non-small cell lung cancer with clinically acquired resistance to gefitinib.

Kim H, Yun T, Lee YJ, Han JY, Kim HT, Lee GK. Kim H, et al. Among authors: han jy. J Korean Med Sci. 2013 Nov;28(11):1595-602. doi: 10.3346/jkms.2013.28.11.1595. Epub 2013 Oct 31. J Korean Med Sci. 2013. PMID: 24265521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,119 results

Search Page

Filters